Articoli di riviste sul tema "Fu ci"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Fu ci".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Methot, N., e K. Basler. "Suppressor of fused opposes hedgehog signal transduction by impeding nuclear accumulation of the activator form of Cubitus interruptus". Development 127, n. 18 (15 settembre 2000): 4001–10. http://dx.doi.org/10.1242/dev.127.18.4001.
Testo completoZhou, Mengmeng, Yuhong Han, Bing Wang, Yong Suk Cho e Jin Jiang. "Dose-dependent phosphorylation and activation of Hh pathway transcription factors". Life Science Alliance 5, n. 11 (5 settembre 2022): e202201570. http://dx.doi.org/10.26508/lsa.202201570.
Testo completoKöhne, C.-H., J. Wils, M. Lorenz, P. Schöffski, R. Voigtmann, C. Bokemeyer, M. Lutz et al. "Randomized Phase III Study of High-Dose Fluorouracil Given As a Weekly 24-Hour Infusion With or Without Leucovorin Versus Bolus Fluorouracil Plus Leucovorin in Advanced Colorectal Cancer: European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952". Journal of Clinical Oncology 21, n. 20 (15 ottobre 2003): 3721–28. http://dx.doi.org/10.1200/jco.2003.11.122.
Testo completoKabbinavar, Fairooz, Herbert I. Hurwitz, Louis Fehrenbacher, Neal J. Meropol, William F. Novotny, Grazyna Lieberman, Susan Griffing e Emily Bergsland. "Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer". Journal of Clinical Oncology 21, n. 1 (1 gennaio 2003): 60–65. http://dx.doi.org/10.1200/jco.2003.10.066.
Testo completoKu, Geoffrey Yuyat, Benjamin Haaland e Gilberto de Lima Lopes. "Cetuximab (C225) in the first-line treatment of advanced colorectal cancer (CRC) patients (Pts) with K-ras wild-type (WT) tumors: Does the choice and schedule of fluoropyrimidine (Fp) matter?" Journal of Clinical Oncology 30, n. 4_suppl (1 febbraio 2012): 576. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.576.
Testo completoWang-Gillam, Andrea, Chung-Pin Li, Gyorgy Bodoky, Andrew Dean, Yang-Shen Shan, Gayle S. Jameson, Teresa Macarulla et al. "Updated overall survival analysis of NAPOLI-1: Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy." Journal of Clinical Oncology 34, n. 4_suppl (1 febbraio 2016): 417. http://dx.doi.org/10.1200/jco.2016.34.4_suppl.417.
Testo completoWagner, Anna D., Wilfried Grothe, Johannes Haerting, Gerhard Kleber, Axel Grothey e Wolfgang E. Fleig. "Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data". Journal of Clinical Oncology 24, n. 18 (20 giugno 2006): 2903–9. http://dx.doi.org/10.1200/jco.2005.05.0245.
Testo completoArkenau, Hendrik-Tobias, Dirk Arnold, Jim Cassidy, Eduardo Diaz-Rubio, Jean-Yves Douillard, Howard Hochster, Andrea Martoni et al. "Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials". Journal of Clinical Oncology 26, n. 36 (20 dicembre 2008): 5910–17. http://dx.doi.org/10.1200/jco.2008.16.7759.
Testo completoNam, Ki-Woong, Chi Kyung Kim, Tae Jung Kim, Kyungmi Oh, Moon-Ku Han, Sang-Bae Ko e Byung-Woo Yoon. "FLAIR vascular hyperintensities predict early ischemic recurrence in TIA". Neurology 90, n. 9 (31 gennaio 2018): e738-e744. http://dx.doi.org/10.1212/wnl.0000000000005034.
Testo completoPoplin, Elizabeth A., Jacqueline K. Benedetti, Norman C. Estes, Daniel G. Haller, Robert J. Mayer, Richard M. Goldberg, Geoffrey R. Weiss, Saul E. Rivkin e John S. Macdonald. "Phase III Southwest Oncology Group 9415/Intergroup 0153 Randomized Trial of Fluorouracil, Leucovorin, and Levamisole Versus Fluorouracil Continuous Infusion and Levamisole for Adjuvant Treatment of Stage III and High-Risk Stage II Colon Cancer". Journal of Clinical Oncology 23, n. 9 (20 marzo 2005): 1819–25. http://dx.doi.org/10.1200/jco.2005.04.169.
Testo completoSisson, Barbara E., Suzanne L. Ziegenhorn e Robert A. Holmgren. "Regulation of Ci and Su(fu) nuclear import in Drosophila". Developmental Biology 294, n. 1 (giugno 2006): 258–70. http://dx.doi.org/10.1016/j.ydbio.2006.02.050.
Testo completoSchilsky, Richard L., Jeremey Levin, William H. West, Alfred Wong, Bruce Colwell, Michael P. Thirlwell, Rafat H. Ansari et al. "Randomized, Open-Label, Phase III Study of a 28-Day Oral Regimen of Eniluracil Plus Fluorouracil Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Therapy in Patients With Metastatic/Advanced Colorectal Cancer". Journal of Clinical Oncology 20, n. 6 (15 marzo 2002): 1519–26. http://dx.doi.org/10.1200/jco.2002.20.6.1519.
Testo completoHoning, Judith, Justin Smit, Christina Muijs, Johannes Burgerhof, Jannet Beukema, John Theodorus Plukker e Geke Hospers. "A comparison of carboplatin with paclitaxel and cisplatinum with 5-fluorouracil in definitive chemoradiotherapy in esophageal cancer patients." Journal of Clinical Oncology 32, n. 3_suppl (20 gennaio 2014): 104. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.104.
Testo completoSultana, Asma, Catrin Tudur Smith, David Cunningham, Naureen Starling, John P. Neoptolemos e Paula Ghaneh. "Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer". Journal of Clinical Oncology 25, n. 18 (20 giugno 2007): 2607–15. http://dx.doi.org/10.1200/jco.2006.09.2551.
Testo completoRao, Sheela, Francesco Sclafani, Cathy Eng, Richard A. Adams, Marianne G. Guren, David Sebag-Montefiore, Al Benson et al. "International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct". Journal of Clinical Oncology 38, n. 22 (1 agosto 2020): 2510–18. http://dx.doi.org/10.1200/jco.19.03266.
Testo completoSchmoll, Hans-Joachim, Josep Tabernero, Jean Alfred Maroun, Filippo G. De Braud, Timothy Jay Price, Eric Van Cutsem, Mark Hill, Silke Hoersch, Karen Rittweger e Daniel G. Haller. "Capecitabine plus oxaliplatin (XELOX) versus bolus 5-fluorouracil/leucovorin (5-FU/LV) as adjuvant therapy for stage III colon cancer: Survival follow-up of study NO16968 (XELOXA)." Journal of Clinical Oncology 30, n. 4_suppl (1 febbraio 2012): 388. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.388.
Testo completoDouillard, Jean-Yves, Paulo M. Hoff, Jamey R. Skillings, Peter Eisenberg, Neville Davidson, Peter Harper, Mark D. Vincent et al. "Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer". Journal of Clinical Oncology 20, n. 17 (1 settembre 2002): 3605–16. http://dx.doi.org/10.1200/jco.2002.04.123.
Testo completoYang Seoung Duk. "A Study on the Ci-Fu Thoughts of Xie-Ling-Yun". Journal of Chinese Language and Literature ll, n. 54 (dicembre 2009): 83–104. http://dx.doi.org/10.15792/clsyn..54.200912.83.
Testo completoYang, Seoung Duk. "A Study on The theory of Dong-Jin,s Ci-Fu". JOURNAL OF CHINESE HUMANITIES 76 (31 dicembre 2020): 223–43. http://dx.doi.org/10.35955/jch.2020.12.76.223.
Testo completoCassidy, J., N. Scotto e E. Diaz-Rubio. "Review of completed and ongoing trials of capecitabine-based adjuvant therapy in patients with early-stage colon cancer." Journal of Clinical Oncology 29, n. 4_suppl (1 febbraio 2011): 495. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.495.
Testo completoMerchant, Mark, Felix F. Vajdos, Mark Ultsch, Henry R. Maun, Ulrich Wendt, Jennifer Cannon, William Desmarais, Robert A. Lazarus, Abraham M. de Vos e Frederic J. de Sauvage. "Suppressor of Fused Regulates Gli Activity through a Dual Binding Mechanism". Molecular and Cellular Biology 24, n. 19 (1 ottobre 2004): 8627–41. http://dx.doi.org/10.1128/mcb.24.19.8627-8641.2004.
Testo completoMaisey, Nick, Ian Chau, David Cunningham, Andrew Norman, Matt Seymour, Tamas Hickish, Tim Iveson et al. "Multicenter Randomized Phase III Trial Comparing Protracted Venous Infusion (PVI) Fluorouracil (5-FU) With PVI 5-FU Plus Mitomycin in Inoperable Pancreatic Cancer". Journal of Clinical Oncology 20, n. 14 (15 luglio 2002): 3130–36. http://dx.doi.org/10.1200/jco.2002.09.029.
Testo completoBertagnolli, Monica M., Donna Niedzwiecki, Carolyn C. Compton, Hejin P. Hahn, Margaret Hall, Beatrice Damas, Scott D. Jewell et al. "Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803". Journal of Clinical Oncology 27, n. 11 (10 aprile 2009): 1814–21. http://dx.doi.org/10.1200/jco.2008.18.2071.
Testo completoWang-Gillam, Andrea, Richard Hubner, Beloo Mirakhur, Floris A. de Jong, Bruce Belanger e Li-Tzong Chen. "Dose modifications of liposomal irinotecan (nal-IRI) + 5-fluorouracil/leucovorin (5-FU/LV) in NAPOLI-1: Impact on efficacy." Journal of Clinical Oncology 36, n. 4_suppl (1 febbraio 2018): 388. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.388.
Testo completoTaïeb, Julien, Tim Maughan, Carsten Bokemeyer, Eric Van Cutsem, Thomas Brodowicz, Gunnar Folprecht, Regina Esser, Michael Schlichting e Josep Tabernero. "Cetuximab combined with infusional 5-fluorouracil/folinic acid (5-FU/FA) and oxaliplatin in metastatic colorectal cancer (mCRC): A pooled analysis of COIN and OPUS study data." Journal of Clinical Oncology 30, n. 15_suppl (20 maggio 2012): 3574. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.3574.
Testo completoWagner, A. D., W. Grothe, J. Haerting, G. Kleber, A. Grothey e W. E. Fleig. "Combination chemotherapies in advanced gastric cancer: An updated systematic review and meta-analysis". Journal of Clinical Oncology 25, n. 18_suppl (20 giugno 2007): 4555. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.4555.
Testo completoSchmoll, Hans-Joachim, Josep Tabernero, Jean Maroun, Filippo de Braud, Timothy Price, Eric Van Cutsem, Mark Hill, Silke Hoersch, Karen Rittweger e Daniel G. Haller. "Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial". Journal of Clinical Oncology 33, n. 32 (10 novembre 2015): 3733–40. http://dx.doi.org/10.1200/jco.2015.60.9107.
Testo completoSizer, B., A. Makris, C. Barone, P. Mainwaring e P. Eggleton. "QoL and resource use analysis of tegafur-uracil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study". Journal of Clinical Oncology 24, n. 18_suppl (20 giugno 2006): 3631. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.3631.
Testo completoKöhne, C. H., E. van Cutsem, J. Wils, C. Bokemeyer, M. El-Serafi, M. P. Lutz, M. Lorenz et al. "Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986". Journal of Clinical Oncology 23, n. 22 (1 agosto 2005): 4856–65. http://dx.doi.org/10.1200/jco.2005.05.546.
Testo completoPeng, Chengwei, Saad Saffo, Michael Shusterman, Daniel Jacob Becker, Jordan Berlin, Paul Eliezer Oberstein, Anil Nagar e Shun Yu. "Analysis of the impact of eliminating bolus 5-fluorouracil in metastatic colorectal cancer." Journal of Clinical Oncology 41, n. 4_suppl (1 febbraio 2023): 59. http://dx.doi.org/10.1200/jco.2023.41.4_suppl.59.
Testo completoFuchs, Charles S., Donna Niedzwiecki, Harvey J. Mamon, Joel E. Tepper, Xing Ye, Richard S. Swanson, Peter C. Enzinger et al. "Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)". Journal of Clinical Oncology 35, n. 32 (10 novembre 2017): 3671–77. http://dx.doi.org/10.1200/jco.2017.74.2130.
Testo completoLi, Jia-yi, Xuan-zhang Huang, Peng Gao, Xiao-wan Chen, Yong-xi Song, Xing-er Lv, Yv Fu, Qiong Xiao e Zhen-ning Wang. "Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment". BioMed Research International 2021 (27 marzo 2021): 1–21. http://dx.doi.org/10.1155/2021/8852699.
Testo completoWang, Aiqing. "Cliché-ridden Online Danmei Fiction? A Case Study of Tianguan ci fu". Acta Asiatica Varsoviensia 35 (2022): 281–314. http://dx.doi.org/10.60018/acasva.iray5065.
Testo completoSchmidt, Jan, Ulrich Abel, Jürgen Debus, Sabine Harig, Katrin Hoffmann, Thomas Herrmann, Detlef Bartsch et al. "Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma". Journal of Clinical Oncology 30, n. 33 (20 novembre 2012): 4077–83. http://dx.doi.org/10.1200/jco.2011.38.2960.
Testo completoModest, Dominik Paul, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Lothar Müller, Alexander Koenig, Ludwig Fischer von Weikersthal et al. "FU/FA maintenance therapy with or without panitumumab (pmab) in RAS wild-type metastatic colorectal cancer (mCRC) (PanaMa, AIO KRK 0212): Updated efficacy analyses." Journal of Clinical Oncology 42, n. 16_suppl (1 giugno 2024): 3506. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3506.
Testo completoYothers, Greg, Patricia A. Ganz, Samia H. Lopa, Clifford Y. Ko, D. Lawrence Wickerham e Norman Wolmark. "Patient-reported outcomes (PROs) comparison of 5-FU and capecitabine (cape) with concurrent radiotherapy (RT) for neoadjuvant treatment of rectal cancer: Results of NSABP R-04." Journal of Clinical Oncology 30, n. 4_suppl (1 febbraio 2012): 391. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.391.
Testo completoSargent, Daniel J., Silvia Marsoni, Genevieve Monges, Stephen N. Thibodeau, Roberto Labianca, Stanley R. Hamilton, Amy J. French et al. "Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer". Journal of Clinical Oncology 28, n. 20 (10 luglio 2010): 3219–26. http://dx.doi.org/10.1200/jco.2009.27.1825.
Testo completoLiu, Guo-Chen, Jun-Ping Yan, Qing He, Xin An, Zhi-Zhong Pan e Pei-Rong Ding. "Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis". Gastroenterology Research and Practice 2016 (2016): 1–10. http://dx.doi.org/10.1155/2016/1798285.
Testo completoFreeman, Karoline, Martin Connock, Ewen Cummins, Tara Gurung, Sian Taylor-Phillips, Rachel Court, Mark Saunders, Aileen Clarke e Paul Sutcliffe. "Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion". Health Technology Assessment 19, n. 91 (novembre 2015): 1–322. http://dx.doi.org/10.3310/hta19910.
Testo completoZafar, Amna, Zsofia D. Drobni, Matthew Lei, Carlos A. Gongora, Thiago Quinaglia, Uvette Y. Lou, Ramya Mosarla et al. "The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm". PLOS ONE 17, n. 4 (7 aprile 2022): e0265767. http://dx.doi.org/10.1371/journal.pone.0265767.
Testo completoIkawati, Muthi, e Endah Puji Septisetyani. "Pentagamavunone-0 (PGV-0), a Curcumin Analog, Enhances Cytotoxicity of 5-Fluorouracil and Modulates Cell Cycle in WiDr Colon Cancer Cells". Indonesian Journal of Cancer Chemoprevention 9, n. 1 (28 febbraio 2018): 23. http://dx.doi.org/10.14499/indonesianjcanchemoprev9iss1pp23-31.
Testo completoSholihah, Imroatus, Meirizky Zulharini S., Amalia Miranda, Refki Riswansyah e Riris Istighfari Jenie. "Jure Leaf Extract (Nerium indium Mill.) Increased 5-Fluorouracil Sensitivity through Inhibition of NF-κB Activation and Transporter Protein in WiDr Colon Cancer Cell". Indonesian Journal of Cancer Chemoprevention 7, n. 3 (1 febbraio 2017): 87. http://dx.doi.org/10.14499/indonesianjcanchemoprev7iss3pp87-92.
Testo completoAl-Thani, Hassan, Ayman El-Menyar, Valsa Koshy, Ahmed Hussein, Ahmed Sharaf, Mohammad Asim e Ahmed Sadek. "Implications of Foot Ulceration in Hemodialysis Patients: A 5-Year Observational Study". Journal of Diabetes Research 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/945075.
Testo completoMohamed, Yehia I., Aliya Qayyum, Manal Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia, Sunyoung S. Lee et al. "Treatment outcome and prognostic indicators in 26 cases of fibrolamellar hepatocellular carcinoma under interferon based therapy." Journal of Clinical Oncology 38, n. 15_suppl (20 maggio 2020): e16626-e16626. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16626.
Testo completoHaller, Daniel G., Josep Tabernero, Jean Maroun, Filippo de Braud, Timothy Price, Eric Van Cutsem, Mark Hill, Frank Gilberg, Karen Rittweger e Hans-Joachim Schmoll. "Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer". Journal of Clinical Oncology 29, n. 11 (10 aprile 2011): 1465–71. http://dx.doi.org/10.1200/jco.2010.33.6297.
Testo completoBang, Kyunghye, Jaekyung Cheon, Jae Ho Jeong, Hyeon-Su Im, Kyu-Pyo Kim, Baek-Yeol Ryoo e Changhoon Yoo. "Efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin after progression on conventional irinotecan-containing chemotherapy for metastatic pancreatic adenocarcinoma." Journal of Clinical Oncology 39, n. 3_suppl (20 gennaio 2021): 382. http://dx.doi.org/10.1200/jco.2021.39.3_suppl.382.
Testo completoBang, Kyunghye, Jaekyung Cheon, Jae Ho Jeong, Hyeon-Su Im, Kyu-pyo Kim, Baek-Yeol Ryoo e Changhoon Yoo. "Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy". Therapeutic Advances in Medical Oncology 13 (gennaio 2021): 175883592110030. http://dx.doi.org/10.1177/17588359211003053.
Testo completoMcCaffrey, J. A., S. Hilton, M. Mazumdar, S. Sadan, M. Heineman, J. Hirsch, W. K. Kelly, H. I. Scher e D. F. Bajorin. "Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma." Journal of Clinical Oncology 15, n. 6 (giugno 1997): 2449–55. http://dx.doi.org/10.1200/jco.1997.15.6.2449.
Testo completoTesta, Luca, Azeem Latib, Nedy Brambilla, Federico De Marco, Claudia Fiorina, Marianna Adamo, Cristina Giannini et al. "Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis". European Heart Journal 41, n. 20 (6 gennaio 2020): 1876–86. http://dx.doi.org/10.1093/eurheartj/ehz925.
Testo completoHendlisz, Alain, Marc Van den Eynde, Marc Peeters, Geert Maleux, Bieke Lambert, Jaarke Vannoote, Katrien De Keukeleire et al. "Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy". Journal of Clinical Oncology 28, n. 23 (10 agosto 2010): 3687–94. http://dx.doi.org/10.1200/jco.2010.28.5643.
Testo completo